Variable | β | SE | Hazard ratio (95%CI) | P value |
---|---|---|---|---|
Overall sruvival | Â | Â | Â | Â |
Clinical stage | 1.382 | 0.468 | 3.982 (1.590-9.974) | 0.003 |
Vascular invasion | 0.895 | 0.258 | 2.448 (1.477-4.059) | 0.001 |
AFP | 0.781 | 0.273 | 2.184 (1.279-3.730) | 0.004 |
Tumor differentiation | 0.599 | 0.299 | 0.550 (0.306-0.988) | 0.045 |
Tumor multiplicity | 0.438 | 0.283 | 1.549 (0.889-2.698) | 0.122 |
AZGP1 | -0.321 | 0.231 | 0.725 (0.461-1.141) | 0.164 |
Tumor size | 0.319 | 0.245 | 1.376 (0.852-2.224) | 0.192 |
Disease-free survival | Â | Â | Â | Â |
Relapse | 1.252 | 0.167 | 3.499 (2.522-4.854) | < 0.001 |
Vascular invasion | 0.775 | 0.206 | 2.171 (1.449-3.253) | < 0.001 |
AFP | 0.533 | 0.173 | 1.705 (1.215-2.392) | 0.002 |
Tumor differentiation | 0.521 | 0.232 | 0.594 (0.377-0.936) | 0.025 |
Tumor size | 0.361 | 0.18 | 1.435 (1.009-2.041) | 0.044 |
Tumor multiplicity | 0.427 | 0.238 | 1.533 (0.962-2.443) | 0.072 |
AZGP1 | -0.211 | 0.166 | 0.810 (0.585-1.121) | 0.204 |
Clinical stage | 0.188 | 0.286 | 1.207 (0.689-2.115) | 0.510 |